ID2
DNA-binding protein inhibitor ID-2
Also known as: bHLHb26, GIG8, ID2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02363
- Gene
- ID2
- Ensembl
- ENSG00000115738
- Chromosome
- 2
- Canonical length
- 134 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear bodies,Centrosome
OverviewNCBI Gene
The protein encoded by this gene belongs to the inhibitor of DNA binding family, members of which are transcriptional regulators that contain a helix-loop-helix (HLH) domain but not a basic domain. Members of the inhibitor of DNA binding family inhibit the functions of basic helix-loop-helix transcription factors in a dominant-negative manner by suppressing their heterodimerization partners through the HLH domains. This protein may play a role in negatively regulating cell differentiation. A pseudogene of this gene is located on chromosome 3. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
134 residues, UniProt reviewed canonical sequence.
>Q02363|ID2
1 MKAFSPVRSV RKNSLSDHSL GISRSKTPVD DPMSLLYNMN DCYSKLKELV PSIPQNKKVS
61 KMEILQHVID YILDLQIALD SHPTIVSLHH QRPGQNQASR TPLTTLNTDI SILSLQASEF
121 PSELMSNDSK ALCGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ID2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 1,137 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 1,137 nTPM
- blood vessel: 790 nTPM
- liver: 539 nTPM
- bone marrow: 368 nTPM
- thyroid gland: 209 nTPM
- ovary: 209 nTPM
Single-cell type
- cdc: 1,027 nCPM
- innate lymphoid cells: 878 nCPM
- endometrial luminal cells: 854 nCPM
- mast cells: 840 nCPM
- goblet cells: 804 nCPM
- syncytiotrophoblasts: 761 nCPM
Immune cell
- eosinophil: 1,041 nTPM
- NK-cell: 883 nTPM
- gdT-cell: 358 nTPM
- naive CD8 T-cell: 263 nTPM
- memory CD8 T-cell: 252 nTPM
- non-classical monocyte: 250 nTPM
Brain region
- cerebral cortex: 162 nTPM
- white matter: 115 nTPM
- thalamus: 107 nTPM
- hypothalamus: 100 nTPM
- basal ganglia: 99 nTPM
- pons: 97 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0.67
- gnomAD missense Z
- 0.02
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adipose tissue development
- adult locomotory behavior
- astrocyte differentiation
- B cell differentiation
- bundle of His development
- cell maturation
- cell morphogenesis involved in neuron differentiation
- cellular response to lithium ion
- cellular senescence
- circadian regulation of gene expression
- circadian rhythm
- dopaminergic neuron differentiation
- embryonic digestive tract morphogenesis
- endodermal digestive tract morphogenesis
- entrainment of circadian clock by photoperiod
- enucleate erythrocyte differentiation
- epithelial cell differentiation involved in mammary gland alveolus development
- heart development
- locomotor rhythm
- mammary gland alveolus development
- mammary gland epithelial cell proliferation
- membranous septum morphogenesis
- metanephros development
- natural killer cell differentiation
- negative regulation of B cell differentiation
- negative regulation of DNA-binding transcription factor activity
- negative regulation of DNA-templated transcription
- negative regulation of dopaminergic neuron differentiation
- negative regulation of gene expression
- negative regulation of muscle cell differentiation
- negative regulation of oligodendrocyte differentiation
- negative regulation of osteoblast differentiation
- negative regulation of transcription by RNA polymerase II
- neuron differentiation
- neuron fate commitment
- olfactory bulb development
- oligodendrocyte development
- Peyer's patch development
- positive regulation of astrocyte differentiation
- positive regulation of blood pressure
- positive regulation of DNA-templated transcription
- positive regulation of erythrocyte differentiation
- positive regulation of fat cell differentiation
- positive regulation of gene expression
- positive regulation of macrophage differentiation
- positive regulation of smooth muscle cell proliferation
- regulation of circadian rhythm
- regulation of G1/S transition of mitotic cell cycle
- regulation of lipid metabolic process
- regulation of neural precursor cell proliferation
- regulation of neuron differentiation
- regulation of transcription by RNA polymerase II
- thigmotaxis
- white fat cell differentiation
Molecular functions
- protein dimerization activity
- RNA polymerase II-specific DNA-binding transcription factor binding
- transcription corepressor activity
- transcription regulator inhibitor activity
- transmembrane transporter binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ID2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ID2 as an antibody target. Whether an autoantibody or antibody against ID2 could matter depends on whether native ID2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ID2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ID2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...